The Accumulation Distribution forecast reference data for Calidi Biotherapeutics is based on the equity's recent trading history. This page summarizes the model output and key accuracy metrics for reference.
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume All Accumulation Distribution forecast figures shown for Calidi Biotherapeutics are reference data reflecting model output based on available historical prices.
Accumulation Distribution Analysis Today
Calidi Biotherapeutics has current Accumulation Distribution of 8661.55. The accumulation distribution (A/D) indicator shows the degree to which Calidi Biotherapeutics is accumulated by the market over a given period. It uses the quote sensitivity to the highest or lowest daily price of Calidi Biotherapeutics to determine if accumulation or reduction is taking place in the market. This value is adjusted by Calidi Biotherapeutics trading volume to give more weight to distributions with higher volume over lower volume.
On March 19 2026 Calidi Biotherapeutics was traded for 0.30 at the closing time. The top price for the day was 0.31 and the lowest listed price was 0.29 . The trading volume for the day was 134.3 K. The trading history from March 19, 2026 did not affect price variability. The overall trading delta against the current closing price is 0.00% .
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
Other Forecasting Options for Calidi Biotherapeutics
Whether a novice or experienced investor, anyone considering Calidi needs to understand the dynamics of Calidi Biotherapeutics' price movement. Price charts for Calidi Stock contain a significant amount of noise that can distort investment decisions.
The following equities are related to Calidi Biotherapeutics within the Health Care space and can be used for peer comparison, relative valuation, or portfolio diversification. Comparing Calidi Biotherapeutics against peers on metrics such as P/E, margins, and return on equity helps contextualize its positioning and identify relative strengths or weaknesses.
Analyzing market strength indicators for Calidi Biotherapeutics enables investors to understand how the stock performs relative to overall market momentum. These indicators are valuable tools for identifying when to enter or exit positions in Calidi Biotherapeutics.
Identifying and analyzing Calidi Biotherapeutics' key risk indicators is a foundational step in projecting how its price may evolve. This process quantifies the risk associated with Calidi Biotherapeutics' and decide how to manage it.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Calidi Biotherapeutics
Story coverage around Calidi Biotherapeutics often expands when market conditions, narrative momentum, or risk-adjusted performance make the security more visible to investors. The stronger process compares story flow with performance, theme classification, and the level of short-term market interest.
Short-interest signals around Calidi Biotherapeutics can help investors judge whether skeptical positioning is starting to pressure price predictability and market tone. This is most valuable when investors want to know whether bearish pressure is starting to shape the market's reaction function.
Common Stock Shares Outstanding
664.4 K
Cash And Short Term Investments
9.6 M
More Resources for Calidi Stock Analysis
Analysis of Calidi Biotherapeutics often begins with its financial statements and historical patterns. Ratios connect earnings, costs, and operational efficiency.
